Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Michael Hughes

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Lymphatic Research and Biology|September 20, 2022
Prospective Surveillance with Compression for Subclinical Lymphedema: Symptoms, Skin, and Quality-of-Life OutcomesMary S Dietrich, Katrina Gaitatzis, Louise Koelmeyer, et al.
Asia-Pacific Journal of Clinical Oncology|September 30, 2017
Correlating Ki67 and other prognostic markers with Oncotype DX recurrence score in early estrogen receptor-positive breast cancerAaron C Tan, Bob T Li, Kazi Nahar, et al.
Cancer|July 7, 2022
Risk factors for breast cancer-related lymphedema in patients undergoing 3 years of prospective surveillance with interventionLouise A Koelmeyer, Katrina Gaitatzis, Mary S Dietrich, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Lymphatic Research and Biology|September 20, 2022
Prospective Surveillance with Compression for Subclinical Lymphedema: Symptoms, Skin, and Quality-of-Life OutcomesMary S Dietrich, Katrina Gaitatzis, Louise Koelmeyer, et al.
Asia-Pacific Journal of Clinical Oncology|September 30, 2017
Correlating Ki67 and other prognostic markers with Oncotype DX recurrence score in early estrogen receptor-positive breast cancerAaron C Tan, Bob T Li, Kazi Nahar, et al.
Cancer|July 7, 2022
Risk factors for breast cancer-related lymphedema in patients undergoing 3 years of prospective surveillance with interventionLouise A Koelmeyer, Katrina Gaitatzis, Mary S Dietrich, et al.
Pageof 2